The researchers, from the Dick Vet Equine Hospital, University of Edinburgh, Newcastle University, Istituto Zooprofilattico Sperimentale delle Venezie, and the University of Padova found that affected horses have major abnormalities in the structure of their neuromuscular junctions, microscopic sites of communication between nerves and muscles that are crucial for normal muscle function.
These abnormalities are believed to represent a toxin specific signature, effectively a ‘smoking gun’, for a neurotoxic enzyme termed a phospholipase A2.
Work is now underway to definitively identify the source of the toxin, in the hope that it will lead to novel treatments and improved diagnostics for this devastating disease.
The researchers think the toxin is likely to be produced by a microbe such as a bacterium or fungus growing on the horse’s pasture during the cold and dry weather which commonly precedes the disease.
Neurotoxic phospholipase A2 toxins are also present in the venom of many poisonous snakes, and there are many similarities between the signs of grass sickness and those of snake envenomation.
While there is no suggestion that venomous snakes cause grass sickness, it is hoped that some of the drugs that are currently being developed to treat and promote nerve regeneration in people paralysed by snake venoms can aid recovery of horses from grass sickness.
The researchers say that the neurotoxin most likely also causes the apparently identical diseases (termed animal dysautonomias) which affect cats, dogs, hares, rabbits, llamas, alpacas and sheep, and that their finding contradicts the previous leading hypothesis that grass sickness is a form of botulism.
This breakthrough is summarised in an editorial in the January 2025 issue of the Equine Veterinary Journal (EVJ).
The editorial, by Bruce McGorum and colleagues, looks at the implications of their article 'Equine grass sickness is associated with major abnormalities in the ultrastructure of skeletal neuromuscular junctions2".
Bruce said: “Identifying a probable cause of Equine Grass Sickness represents a significant breakthrough.
"We hope that this discovery will lead to novel treatments and improved diagnostics for this devastating condition.
"We are very grateful for the generous support we have received from horse owners, veterinary surgeons, scientists, charities and funding bodies.”
Bruce's editorial is currently available on Early View, free for 12 weeks, and will also be published in the January 2025 print issue of the EVJ.
Reference
The webinar will be presented by Dr Abigail McGlennon from the Equine Infectious Disease Surveillance (EIDS) team at the University of Cambridge who will present data from the Surveillance of Equine Strangles (SES) network to provide a detailed overview of strangles diagnoses across the UK.
Abigail will explore recent trends in outbreak reports, the genetic makeup of recent circulating strains and transmission links between UK outbreaks.
By linking research from her own PhD work on S. equi genomics and transmission with preventative strategies, Abigail show how to suggest and implement evidence-based prevention measures to clients.
The webinar will also offer advice on ‘the ates’ preventative measures – vaccinate, isolate, investigate and communicate – and will include information on when horse owners should be vaccinating with Strangvac and an outbreak management vaccination plan using the traffic light ‘green, amber and red’ system.
https://go.dechra.co.uk/preventative_strategies_for_strangles
The company now expects the vaccine will not be available until June 2025.
The company apologised for the disruption and inconvenience and says it will provide more information as soon as it becomes available.
For further information contact your Zoetis Account Manager or call Head Office on 0345 300 8034.
The new resources include:
Celia Marr, chair of BEVA’s infectious disease working group, said: “Equine disease prevention and management are fundamental for responsible equine health, welfare and performance.
“These resources cover the need-to-know information and are all in one easy reverence location on the newly designed infection control page on the BEVA website.”
https://www.beva.org.uk/Resources/Equine-infectious-diseases
The farriery stream will run all day on Saturday 14 September, with content curated by Dr Simon Curtis who is internationally renowned in the hoof-care world for his remedial farriery textbooks and lectures.
Simon said: “Any historical, perceived divide between science of veterinary medicine and the craft of farriery is no longer in existence.
"The overlap is vast which means it is more essential than ever that vets, nurses and farriers understand each other’s roles in order to maximise their patient outcomes.”
“Farriery isn’t sexy, but it beats everything else for improving soundness.
"It is impossible to maintain or regain soundness without farriery being considered as an integral part of the process.
“The impact good farriery can have on a horse’s ability to tolerate conformational, work-related or other causes of lameness associated pathology is all too often overlooked by all parties, and this should no longer be the case.
"Vets and farriers must work as a team to avoid injury and facilitate recovery wherever possible.”
The sessions will cover things like the importance of trimming, the biomechanical effects of horseshoes, why heels collapse, chronic club foot, digital support and toe-trimming.
The farriery stream is part of 90+ hours of live and on-demand CPD on offer at Congress, with interactive discussions, debates and workshops, and an expanded stream for vet nurses.
https://www.bevacongress.org/programme
BEVA members prices for Congress for all three days are £699 for vets (with concessionary prices available for those in their first three years of graduation or earning less than £25,000), £273 for nurse members for all three days and £300 for farriers and other allied professionals for all three days or £110 for one day.
Practice passes are also available.
A team of researchers led by Tim Mair, CVS Equine Veterinary Director and Specialist in both Equine Internal Medicine and Equine Soft Tissue Surgery at Bell Equine Veterinary Clinic, will review 100 cases of colitis in adult horses and 100 controls referred to seven equine veterinary hospitals in the UK: five CVS equine veterinary hospitals as well as Rossdales Equine Hospital and University of Liverpool’s equine hospital.
A set of diagnostic tests on blood and faeces will be performed in these cases.
The laboratory tests will include: small redworm serology, culture and PCR of faeces for Salmonella spp, PCR of faeces for Clostridioides difficile and Clostridium perfringens, ELISA of faeces for toxins of C.difficile and C.perfringens, PCR of faeces for coronavirus.
The clinical features, laboratory results, treatments and outcomes will also be recorded.
Tim said: “Acute colitis accounts for around 5% of admissions to referral hospitals.
"And of those who are referred with it, half will not survive but there is very limited evidence available.
"So it’s vital that we build our evidence-base of this life-threatening condition.
"We hope that the outcomes of our new study will lead to a greater understanding of the causes and better inform veterinary treatment of colitis in UK adult horses.”
The Colitis in Adult Horses study is supported by a research grant from CVS, and funding for the small redworm ELISA will be given from Austin Davis Biologics.
The study started at the beginning of 2024 and the first horses have been recruited.
The results of the study are expected to be published in 2025.
Research published in EVE by Pearson in 2020 reported that 95% of equine vets work with “difficult” horses on at least a monthly basis, and that 81% of them had sustained at least one injury in the last 5 years.
The research also indicated that some vets overestimate their understanding of equine learning theory.
The BEVA says developing an extended understanding of how horses learn can make clinical care less stressful, and that reduced patient stress also improves workplace safety, which is important in a role that has been identified as one of the most dangerous civilian professions.
Gemma said: “Horses have limited cognitive skills and so we should try to better understand what motivates and reinforces unwanted behaviours rather than assuming the horse is being wilfully or maliciously disobedient.
“To do this we need to appreciate how horses learn.
"Better horse handling leads to happier horses, and this means happier vets and nurses and owners/clients with the ultimate knock on of better safety, better job satisfaction and better retention in the profession.”
The training sessions include:
Gemma added: “One of the biggest push backs I get from people that haven’t started to develop low stress vet care as a routine is that they haven’t got time. But those who do use it say that it saves them time and keeps them safer, this also brings obvious commercial benefit to the practice - so what’s not to like?”
https://www.beva.org.uk/elearning-redirect?redirect=/course/view.php?id=622
The Arthrex Vet Systems Mobile Lab will be hosting hands-on sessions to help practitioners develop their arthroscopy and joint block skills in its state-of-the-art laboratory.
BEVA President Roger Smith said: “Our practical sessions are always highly popular and the wetlab experience takes things to the next level."
"The ability to practice ultrasound-guided injections at the conference provides the opportunity to hone your skills in ultrasound and enable you to cement to ultrasound-guided injections of tendons and ligaments and joints into your daily practice.
On the Thursday there will be three wetlab taster sessions at three different stations, giving delegates the chance to sharpen their skills with an ultrasound scanner, arthroscope and arthrobox.
Friday’s sessions will be focused on forelimb joint blocks and arthroscopic demonstrations of the needle locations.
The full BEVA Congress programme is now live and super early bird tickets are available until 7th June 2024.
Individual super early bird BEVA members prices are £524 for vets and £144 for vet nurses for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
http://www.bevacongress.org
Dr Wendy Talbot BVSc DipECEIM MRCVS, Equine National Veterinary Manager at Zoetis said: “Fast equine faecal egg count results are crucial for the appropriate and timely treatment of gastrointestinal parasites, and to detect the increasingly concerning issue of dewormer resistance in horses.
"This technology is proven to be as accurate at identifying Strongyle spp. and Parascaris spp. as a board-certified parasitologist, delivering fast, reliable and shareable results within 10 minutes.1”
Zoetis says study results have demonstrated the AI capability within the Vetscan Imagyst to be up to 99% in agreement with board-certified parasitologist results1.
This, says the company, allows for rapid identification of high shedders versus low shedders to enable strategic targeted deworming protocols to be implemented.
The full BEVA Congress programme is now live and super early bird tickets are available from 4th March, saving member delegates up to £200.
The one medicine thread will run through the medicine and orthopaedics and sports medicine streams as well as feature in the Peter Rossdale Plenary Lecture.
BEVA President Roger Smith said “There is much to learn from the human side as well as from what we do as vets.
"We have invited five human medical experts to make some comparative links with human medicine in their presentations.
"Bringing a different angle in this way will help predict what the future holds and advance what we do in the equine veterinary sphere.”
The full programme includes more than 90 hours of live and on-demand CPD covering almost every aspect of equine medicine, surgery and practice.
The first day will commence with an opening address from Olympic gold medallist Sally Gunnell during which she will share her thoughts on maximising performance.
Other highlights include:
Super early bird ends on Wednesday 29 May 2024.
www.bevacongress.org
Despite being a common disease, CVS says very little research has been undertaken into EPD in the UK.
In addition, numerous different treatments are currently used for EPD, for which there is not always robust scientific evidence.
The CVS study, which started in 2022 and will continue till early 2024, involves 20 practices.
Samples have been collected from over 70 cases from horses that have been diagnosed by EPD throughout the UK.
Full blood profiles have been assessed, in addition to bacterial culture analysis of the lesions, PCR analysis for dermatophytes (ringworm fungi), microscopy for ectoparasites (mites) and skin cytology.
An owner questionnaire has also been completed to gather information on EDP management.
Each horse’s lesions have been graded and descriptive data relating to the lesions were recorded.
Data collection is now complete and a team of researchers, led by vet Manuela Diaz Ramos, has started analysing the data.
A full report on the findings, along with treatment and management recommendations, is expected to be presented at a scientific conference later this year.
Pergocoat contains pergolide, a long-acting dopamine receptor agonist.
It is available in 0.5mg (off-white) and 1mg (yellow) tablets for accurate dosing without the need to split tablets.
The tablets are film-coated to mask the bitter taste of pergolide and create a barrier between the horse owner and the active ingredient.
Available in two different pack sizes containing 60 or 160 tablets, Pergocoat tablets are packaged in double layered blister packs to help minimise the risk of accidental ingestion.
Rachel Addison BVM&S MRCVS, equine field support manager at Dechra said: “Pergocoat is available in two convenient tablet sizes to achieve an optimal treatment response.
"Horses can be monitored and reviewed every four to six weeks until stabilisation or improvement of clinical signs is observed.”
https://www.dechra.co.uk/products/horse/prescription/pergocoat#Pergocoat-0-5mg-60-film-coated-tablets-for-horses.
The survey of 2717 horse owners, 56% of which were leisure owners and 35% professionals, found that most horses (62%) were retired between 15-24 years of age, mainly for health reasons.
Mares had a higher risk of retirement than geldings, which the researchers say may be due in part to mares used for breeding not doing much structured exercise.
Just over 1 in 6 horses in the study were affected by low muscle mass according to their owners.
Age, sex, osteoarthritis, laminitis, pituitary pars intermedia dysfunction (PPID), and primary use were identified as risk factors for low muscle mass.
Geldings had a higher risk of low muscle mass than mares, which the researchers say may be a result of low testosterone.
Horses with owner-reported veterinary-diagnosed PPID, osteoarthritis and laminitis had a higher risk of low muscle mass.
Primary use was identified as a risk factor for low muscle mass, with retired horses having a higher risk than horses used for competition or pleasure riding.
Owner-reported low muscle mass was perceived to affect welfare and the ability to work in the majority of senior horses.
Alisa Herbst, who led the study, said: “A prolonged working/active life may not only be desired by owners but is also likely to provide health and welfare benefits to the horse.
"We hope the results of this study may be useful for veterinarians caring for senior and geriatric equines, by helping to achieve this."
“The information may aid in the investigation of diseases affecting senior horses and in establishing senior horse-owner education programs.
"The low muscle mass risk factor list may assist vets in identifying horses at risk of low muscle mass to be selected for close monitoring.
“Vets may also consider inclusion of an objective measurement of muscle atrophy, such as the muscle atrophy scoring system (MASS)***, in annual wellness exams, so that atrophy can be identified and managed as early as possible."
Sarah Nelson, Product Manager at Mars Horsecare added: “This survey has highlighted several interesting retirement trends.
“With a better understanding of when and why senior horses are being retired we hope, eventually, to be better placed to monitor for, prevent (where possible), and treat the underlying conditions early on, to help horses stay active and healthy for longer.”
https://www.seniorhorsehealth.com
Practices which want to buy the alternative imported vaccine will need to apply to the VMD for a Special Import Certificate (SIC).
Wholesalers have agreed to stock the alternative vaccine.
Zoetis says it acknowledges the concern and frustration this causes its customers and wants to reassure the equine community that it is working hard to resume Equip Rotavirus supply as soon as possible.
For further information, contact your Zoetis account manager or ring Zoetis HQ on 0345 300 8034.
Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters associated with severe equine asthma, previously known as recurrent airway obstruction (RAO).
Equisolon Jar contains 180g of powder and comes with a measuring spoon.
One scoop is enough to treat 150kg bodyweight at a dose of 1mg/kg and therefore one jar can treat a 600kg horse for 10 days.
Equisolon was previously available as a box of 10 x 9g pre-measured sachets with one sachet sufficient to treat a 300kg horse and a box contained enough sachets to treat a 600g horse for five days.
Alana McGlade, national sales manager at Dechra said: “The addition of Equisolon Jar to the Equisolon range provides vets with the flexibility to choose between a jar featuring a convenient measuring spoon and a box of easy to dose pre-measured sachets
www.dechra.co.uk/products/horse/prescription
The survey of 50 vets carried out in May this year1 found that only half of them are recommending strangles vaccination to their clients.
They also felt that horse owners could be doing more to combat the disease.
Less than half of vets questioned believed that yards and premises operated good biosecurity measures prior to a strangles outbreak, yet 85% brought in more stringent biosecurity after an outbreak, when it was too late.
Dechra says that vets and horse owners can help combat the estimated 300 outbreaks of strangles each year with the following steps:
Sara Barker BVSc CertAVP(EM) MRCVS, equine field support manager at Dechra, said: “Strangles is one of the most common equine infectious diseases both in the UK and worldwide and a multi-factor approach is key to tackling the disease.
"Strangles vaccination is recommended, alongside good biosecurity, quarantine measures and regular temperature checking.
"By working together, vets and horse owners can help to keep horses healthy and prevent the spread of strangles.”
The new packaging uses fewer plastic components and a new cardboard box.
Sabrina Jordan, Virbac’s Equine Product Manager said: "The new cardboard component is a substantial step forward making the new packaging more environmentally friendly."
She added: "This new Equimax packaging has a fresh new look and is now available at wholesalers."
Vets with Horsepower is organised annually by Professor Derek Knottenbelt to help raise funds for equine and human charities around the world.
This year the group undertook an endurance motorbike trip of over 1600 miles: from the UK to Germany, across Scandinavia and back, hosting education events for equine vets along the way to raise funds for four charities including BEVA's Power for Ukraine.
BEVA Council member Alison Talbot, said: “Thanks to the generosity of equine vets in the UK we had just hit the halfway mark of raising £10,000, before Vets with Horsepower set off on their epic Scandinavian mission.
"We are so grateful for their donation of £9922 which means we can now buy another five generators, to help twice as many vets and horses in extremely difficult circumstances during enforced power cuts."
The generators will be transported to a collection point in Poland and then on to Ukraine in time for winter.
Donations to the BEVA Trust Power To Ukraine appeal can be made here: https://www.justgiving.com/campaign/powertoukraine
Any surplus funds will be added to the general fund to support equids in Ukraine.
Preliminary results, which recorded a decline in the quantities of antimicrobials prescribed from 2014 to 2018, were published in 2022.
A further audit has now been undertaken in all 22 of the company's first opinion practices to investigate the age, breed and estimated weight of each horse, the clinical indication for antibiotic use, the drugs prescribed, their dose rates, the route of administration and whether culture and sensitivity were used to guide antimicrobial selection.
Data collection was completed in August 2022.
This secondary audit was conducted using a ‘point prevalence’ survey, in which each CVS Equine first opinion Quality Improvement Lead gathered information about all systemic antibiotics prescribed by each of their practices on one day a month for 12 consecutive months.
The project yielded information on 331 cases where systemic antimicrobials were prescribed.
Complete data about the first line-drug selection were available for 261 prescriptions.
The commonest prescribed antimicrobial was sulfadiazine/trimethoprim (41%), followed by oxytetracycline (23%), procaine penicillin (16%), doxycycline (13%), gentamicin (4%), metronidazole (1%), ceftiofur (1%) and enrofloxacin (1%).
Highest priority critically important antimicrobials (ceftiofur and enrofloxacin) were only prescribed in four horses (clinical indications for these included possible sepsis, skin infection, lower respiratory tract infection and a wound complication – in none of these cases was the first-line drug selection based on the results of culture and sensitivity.
Overall, the clinical indications for antimicrobial use were recorded in 246 cases; the commonest indications were cellulitis/lymphangitis (27%), uncomplicated wounds (19%), surgical prophylaxis (15%), respiratory infections (11%) and skin infections (8%).
Hattie Lawrence, Director of CVS Equine, said: “Though the impact of this work is yet to be documented, there is anecdotal evidence that it has raised awareness amongst our veterinarians of the importance of antimicrobial stewardship.
"Taken together, the results of both pieces of work will be used to help develop and inform clinical audits and clinical guidelines of antimicrobial use in horses.”
Thus far, the hospital has relied on conventional radiographs or referred for MRI for the bulk of its distal limb imaging.
The new Hallmarq standing CT scanner provides information that surpasses the capabilities of radiography, while also reducing radiation exposure to the patients and staff.
The scanning process is also considerably quicker, enabling prompt diagnosis and treatment planning.
Tom McParland, Valley Equine Hospital’s surgeon said: "We are confident that this diagnostic modality will significantly enhance our ability to identify not just thoroughbred fetlock pathology earlier but improve our diagnostic abilities of the distal limb for all our equine patients, racing and leisure alike.”
Valley Equine Hospital says it chose the Hallmarq standing CT scanner due to its ability to scan using just standing sedation which ensures a safer and more efficient experience for the horses compared to general anaesthesia.
www.valleyequinehospital.co.ukinfo.hallmarq.net/focus-on-the-foot
The event is held every four years and hosted alternately by BEVA and the American Association of Equine Practitioners (AAEP).
It offers the opportunity for equine vets to absorb and digest the latest knowledge, clinical practice and scientific advances in the treatment and prevention of colic, from the world’s leading international equine gastroenterology experts.
Held over 2.5 days, the symposium comprises numerous 12-minute oral presentations on a range of topics including surgical techniques, treatment, parasitology, gastric ulceration, endotoxemia, pharmacology of intestinal motility, colic complications, epidemiology, physiology of digestion, the intestinal microbiome and metabolomics.
Each session will be followed by three minutes for questions and discussion.
Poster sessions on the first two days will cover ground beyond the oral presentations and delegates will be able to review and discuss the work with presenters.
There will also be opportunities to network with other equine vets, researchers and professionals.
Clinicians and scientists have until 1 February 2024 to submit abstracts of recent work that they wish to present at this meeting.
The scientific committee will consider abstracts on all aspects of equine gastroenterology, including basic science research and reports of clinical cases or novel approaches to treatment.
The abstract submission form is here: https://form.jotform.com/230473925626359
Tickets cost £475 (with a concessionary rate of £235 for post graduate students and interns) and includes a drinks reception on both 10th & 11th, an evening buffet and Ceilidh on 11th and lunch on 11th & 12th.
Further information and booking details can be found here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1740
The survey will assess vets’ experiences of the disease, biosecurity and the role of vaccination to help prevent strangles.
It includes questions on the number of strangles cases diagnosed in the last year, how the diagnosis was reached and in what instances they would recommend strangles vaccination.
The survey, which is approximately two minutes long, is at: https://forms.office.com/e/wH1UeVFmVW.
All participants will be entered into a prize draw for a £50 Amazon voucher.
For further information on Strangles Awareness Week: https://www.redwings.org.uk/strangles/strangles-awareness-week.
Jonathon is an RCVS & EBVS European Specialist in Veterinary Diagnostic Imaging, with a particular interest in MRI of the distal limb and has published scientific work on this subject, among others.
With the increase in availability and accessibility to CT for horses, VetCT says this hot topic will be well received by equine vets at all levels of experience.
VetCT’s Equine Teleradiology Manager, Charlotte Graham, said: “We can guarantee a highly engaging talk with plenty of useful tips on case selection for each modality as well as some interesting discussions in the Q&A session.”
To register for the webinar on 18th April and receive links to recordings of this and previous webinars in the 2023 series, sign up here: https://vetct.zoom.us/webinar/register/WN_zkctYZYWRUmRVIFTxrvvsA
www.vet-ct.com
The DC heard that Mr Hutton had attended to a horse called Angel at a livery yard in Sheffield.
As he examined the horse, it kicked Mr Hutton in the leg, whereupon he kicked it back in the abdomen.
Mr Hutton admitted the facts of the allegation against him.
The Committee noted that there was a dispute between the parties about the exact manner in which the kick had been administered and whether the conduct amounted to disgraceful conduct.
Both the College and the defence obtained the opinion of experts, who were not in agreement as to whether the conduct amounted to serious professional misconduct.
The Committee heard evidence from Angel’s owner, Ms A, who was present when Mr Hutton kicked Angel and from Ms B, Mr Hutton’s life partner, who was also present.
In his witness statement, Mr Hutton said that his kick “was an instinctive reaction to what had happened and an instinctive reprimand for what I felt in the aftermath of the kick from her was malicious behaviour”.
Mr Hutton also stated that the reprimand was an appropriate response which a horse would understand, in order to modify its future behaviour.
In the hearing, Mr Hutton apologised for the incident with Angel. He said it had happened in the heat of the moment. He wished that he had apologised straight away.
In his expert evidence before the Committee, Mr T Gliddon MRCVS, called by the College, agreed that attitudes to physical reprimands had changed over time.
In his expert report, he stated that a reprimand administered by a veterinary surgeon that may have been considered acceptable by a significant body of the veterinary profession some decades ago would no longer be regarded as such now, in his opinion.
In re-examination, he stated that in his opinion, there was not a reasonable body of veterinary opinion which would consider kicking a horse as an acceptable form of negative reinforcement of behaviour.
In his expert evidence to the Committee, Dr H Tremaine FRCVS, called by Mr Hutton, stated that in the case of the minority of veterinary surgeons who used physical reprimands as a means of modifying behaviour, he was not aware that such reprimands would include the use of a kick.
The Committee concluded from the evidence that, following the kick from Angel, Mr Hutton moved away from the horse, so that he was no longer in immediate danger and that his kick in response had come after a gap in time, albeit brief.
Ms Greaney, Counsel for the College, provided written submissions on serious professional misconduct, submitting that principles 1.1 (Veterinary surgeons must make animal health and welfare their first consideration when attending to animals) and 6.5 (Veterinary surgeons must not engage in any activity or behaviour that would be likely to bring the profession into disrepute or undermine public confidence in the profession) of the Code of Professional Conduct had been breached.
It was submitted that, on the basis that there had been a deliberate decision by Mr Hutton to kick Angel in the abdomen, he had time to consider his actions.
The College submitted that deliberately kicking Angel, either as punishment or by way of teaching or training a horse, fell far below the standard expected of veterinary surgeons.
The Committee found Mr Hutton’s state of mind when kicking Angel was not an issue and that Mr Hutton had intentionally kicked the horse.
In reaching its decision in relation to whether Mr Hutton’s conduct amounted to serious professional misconduct the Committee took into account that:
Mrs Judith Way, chairing the Committee and speaking on its behalf, said: “The Committee determined that taking all circumstances and its findings into account, this conduct was a single, but serious failure on the part of Mr Hutton and found the facts proved amounted to disgraceful conduct in a professional respect.
“On deciding what, if any, sanction ought to be imposed, the Committee considered the aggravating and mitigating factors of the case, based on findings at the earlier stages of the hearing.
"The Committee found that there had been a risk of physical and/or mental injury to Angel from Mr Hutton’s conduct but accepted that there were a number of mitigating factors.
“It had been found that the incident had occurred over a very brief period and that Mr Hutton had not taken proper time to consider his response to Angel’s unexpected kick.
"This was found to be a single isolated incident and the character evidence indicated that otherwise, Mr Hutton was a competent and well-regarded veterinary surgeon.
"Mr Hutton admitted the kick early on in the proceedings and had issued an early apology, albeit seeking initially to raise some justification for his actions.
“The Committee was persuaded, in light of Mr Hutton’s admissions, heartfelt apologies, developing insight and the testimonial evidence, that he is very unlikely to repeat his past misconduct.
"However, despite the low risk of repetition, the Committee considered that the nature of the kick, delivered without the consent of the owner, could undermine public confidence in the profession.
"Thus, the Committee considered that it was proportionate to issue a reprimand together with a warning as to Mr Hutton’s future conduct.
"It has determined that this would be proportionate and sufficient to provide adequate protection for animals and maintain public confidence in the profession.”
The full details of the hearing and the Committee’s decision can be found at www.rcvs.org.uk/disciplinary.